What happened
The Ministry of Science & Technology announced the establishment of BioEnablers—including Bio-Artificial Intelligence (AI) Hubs, Biofoundries, and Biomanufacturing Hubs—across India under the BioE3 policy direction. Two call-for-proposals exercises were announced for setting up Biofoundries and Biomanufacturing Hubs to provide shared infrastructure/facilities and resources for pilot and pre-commercial scale biomanufacturing of viable commercial bio-based products. The Ministry stated that more than 450 proposals were received across six thematic verticals and that 17 facilities received funding support under the first call for BioEnablers. DBT and BIRAC jointly issued a call for proposals for “मूलांकुर Bio-AI Hubs” under BioE3; the government statement records that 284 Letters of Intent (LoIs) were received and 15 Bio-AI Hubs were recommended for support. An MoU was also signed with Meity for access to national AI infrastructure by the Bio AI Hubs.
Background and earlier position
BioE3 is used in Indian policy discourse to create an enabling ecosystem for the bioeconomy—linking research and innovation capacity with industrial adoption through infrastructure and institutional mechanisms. Within this ecosystem, BioEnablers such as Biofoundries and biomanufacturing hubs are designed as enabling infrastructure models that allow multiple stakeholders (start-ups, SMEs, industries and academia) to access common pilot and pre-commercial manufacturing capabilities.
What changed now
The current announcement is a quantitative expansion signal: it adds two proposal calls focused specifically on Biofoundries and Biomanufacturing Hubs with a stated objective of enabling pilot and pre-commercial scale biomanufacturing for commercial bio-based products. It also records the outcomes of the “मूलांकुर Bio-AI Hubs” call: 284 LoIs received and 15 Bio-AI Hubs recommended for support, plus an MoU with Meity for access to national AI infrastructure for these hubs.
Related current affairs
- Cabinet approval and ongoing implementation of BioE3 policy: biomanufacturing, hubs and project funding
- BioE3 strain resource centre at BRIC-NCCS Pune to enable indigenous microbial strains with freedom-to-operate
- NITI Aayog launches roadmap to build India as a leading bioeconomy powerhouse by 2035
- Jitendra Singh urges wider awareness about Rs 1 lakh crore RDI Fund for eligible applicants
- Tasers to ‘Tavis’ request/feature: Taxing “Tanjung”: Research capital and India academy funding dependence
- Jitendra Singh seeks enhanced private sector participation in India’s biotechnology ecosystem through BIRAC-RDIF
